/Abstract 577: First-in-class Claudin 18.2 targeting radiopeptide, 64Cu-PD-29875 and 177Lu-PD-29875, exhibit promising theranostic potential in a pancreatic cancer xenograft model
Reviews
Join the dialogue
Submit a peer review to improve the scientific record